List of Tables
Table 1. Global Injectable HIV Treatment Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Injectable HIV Treatment Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Injectable HIV Treatment Market Competitive Situation by Manufacturers in 2025
Table 4. Global Injectable HIV Treatment Sales (K Units) of Key Manufacturers (2021–2026)
Table 5. Global Injectable HIV Treatment Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Injectable HIV Treatment Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Injectable HIV Treatment Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Injectable HIV Treatment Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Injectable HIV Treatment, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Injectable HIV Treatment, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Injectable HIV Treatment, Product Types and Applications
Table 12. Global Key Manufacturers of Injectable HIV Treatment, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Injectable HIV Treatment Companies by Tier (Tier 1, Tier 2, Tier 3), based on Injectable HIV Treatment Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Injectable HIV Treatment Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Injectable HIV Treatment Sales by Region (K Units), 2021–2026
Table 18. Global Injectable HIV Treatment Sales Market Share by Region (2021–2026)
Table 19. Global Injectable HIV Treatment Sales by Region (K Units), 2027–2032
Table 20. Global Injectable HIV Treatment Sales Market Share by Region (2027–2032)
Table 21. Global Injectable HIV Treatment Revenue by Region (US$ Million), 2021–2026
Table 22. Global Injectable HIV Treatment Revenue Market Share by Region (2021–2026)
Table 23. Global Injectable HIV Treatment Revenue by Region (US$ Million), 2027–2032
Table 24. Global Injectable HIV Treatment Revenue Market Share by Region (2027–2032)
Table 25. North America Injectable HIV Treatment Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Injectable HIV Treatment Sales by Country (K Units), 2021–2026
Table 27. North America Injectable HIV Treatment Sales by Country (K Units), 2027–2032
Table 28. North America Injectable HIV Treatment Revenue by Country (US$ Million), 2021–2026
Table 29. North America Injectable HIV Treatment Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Injectable HIV Treatment Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Injectable HIV Treatment Sales by Country (K Units), 2021–2026
Table 32. Europe Injectable HIV Treatment Sales by Country (K Units), 2027–2032
Table 33. Europe Injectable HIV Treatment Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Injectable HIV Treatment Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Injectable HIV Treatment Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Injectable HIV Treatment Sales by Region (K Units), 2021–2026
Table 37. Asia Pacific Injectable HIV Treatment Sales by Region (K Units), 2027–2032
Table 38. Asia Pacific Injectable HIV Treatment Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Injectable HIV Treatment Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Injectable HIV Treatment Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Injectable HIV Treatment Sales by Country (K Units), 2021–2026
Table 42. Latin America Injectable HIV Treatment Sales by Country (K Units), 2027–2032
Table 43. Latin America Injectable HIV Treatment Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Injectable HIV Treatment Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Injectable HIV Treatment Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Injectable HIV Treatment Sales by Country (K Units), 2021–2026
Table 47. Middle East and Africa Injectable HIV Treatment Sales by Country (K Units), 2027–2032
Table 48. Middle East and Africa Injectable HIV Treatment Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Injectable HIV Treatment Revenue by Country (US$ Million), 2027–2032
Table 50. Global Injectable HIV Treatment Sales (K Units) by Type (2021–2026)
Table 51. Global Injectable HIV Treatment Sales (K Units) by Type (2027–2032)
Table 52. Global Injectable HIV Treatment Sales Market Share by Type (2021–2026)
Table 53. Global Injectable HIV Treatment Sales Market Share by Type (2027–2032)
Table 54. Global Injectable HIV Treatment Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Injectable HIV Treatment Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Injectable HIV Treatment Revenue Market Share by Type (2021–2026)
Table 57. Global Injectable HIV Treatment Revenue Market Share by Type (2027–2032)
Table 58. Global Injectable HIV Treatment Price (US$/Unit) by Type (2021–2026)
Table 59. Global Injectable HIV Treatment Price (US$/Unit) by Type (2027–2032)
Table 60. Global Injectable HIV Treatment Sales (K Units) by Application (2021–2026)
Table 61. Global Injectable HIV Treatment Sales (K Units) by Application (2027–2032)
Table 62. Global Injectable HIV Treatment Sales Market Share by Application (2021–2026)
Table 63. Global Injectable HIV Treatment Sales Market Share by Application (2027–2032)
Table 64. Global Injectable HIV Treatment Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Injectable HIV Treatment Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Injectable HIV Treatment Revenue Market Share by Application (2021–2026)
Table 67. Global Injectable HIV Treatment Revenue Market Share by Application (2027–2032)
Table 68. Global Injectable HIV Treatment Price (US$/Unit) by Application (2021–2026)
Table 69. Global Injectable HIV Treatment Price (US$/Unit) by Application (2027–2032)
Table 70. ViiV Healthcare Company Information
Table 71. ViiV Healthcare Description and Business Overview
Table 72. ViiV Healthcare Injectable HIV Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. ViiV Healthcare Injectable HIV Treatment Product
Table 74. ViiV Healthcare Recent Developments/Updates
Table 75. Janssen Pharmaceuticals Company Information
Table 76. Janssen Pharmaceuticals Description and Business Overview
Table 77. Janssen Pharmaceuticals Injectable HIV Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. Janssen Pharmaceuticals Injectable HIV Treatment Product
Table 79. Janssen Pharmaceuticals Recent Developments/Updates
Table 80. Gilead Sciences Company Information
Table 81. Gilead Sciences Description and Business Overview
Table 82. Gilead Sciences Injectable HIV Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. Gilead Sciences Injectable HIV Treatment Product
Table 84. Gilead Sciences Recent Developments/Updates
Table 85. Theratechnologies Company Information
Table 86. Theratechnologies Description and Business Overview
Table 87. Theratechnologies Injectable HIV Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 88. Theratechnologies Injectable HIV Treatment Product
Table 89. Theratechnologies Recent Developments/Updates
Table 90. Key Raw Materials Lists
Table 91. Raw Materials Key Suppliers Lists
Table 92. Injectable HIV Treatment Distributors List
Table 93. Injectable HIV Treatment Customers List
Table 94. Injectable HIV Treatment Market Trends
Table 95. Injectable HIV Treatment Market Drivers
Table 96. Injectable HIV Treatment Market Challenges
Table 97. Injectable HIV Treatment Market Restraints
Table 98. Research Programs/Design for This Report
Table 99. Key Data Information from Secondary Sources
Table 100. Key Data Information from Primary Sources
Table 101. Authors List of This Report
List of Figures
Figure 1. Product Picture of Injectable HIV Treatment
Figure 2. Global Injectable HIV Treatment Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Injectable HIV Treatment Market Share by Type: 2025 & 2032
Figure 4. Cabotegravir Product Picture
Figure 5. Rilpivirine Product Picture
Figure 6. Lenacapavir Product Picture
Figure 7. Ibalizumab Product Picture
Figure 8. Other Product Picture
Figure 9. Global Injectable HIV Treatment Market Value by Application (US$ Million), 2021–2032
Figure 10. Global Injectable HIV Treatment Market Share by Application: 2025 & 2032
Figure 11. Pre-Exposure Prophylaxis
Figure 12. HIV Treatment
Figure 13. Global Injectable HIV Treatment Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 14. Global Injectable HIV Treatment Market Size (US$ Million), 2021–2032
Figure 15. Global Injectable HIV Treatment Sales (K Units), 2021–2032
Figure 16. Global Injectable HIV Treatment Average Price (US$/Unit), 2021–2032
Figure 17. Injectable HIV Treatment Report Years Considered
Figure 18. Injectable HIV Treatment Sales Share by Manufacturers in 2025
Figure 19. Global Injectable HIV Treatment Revenue Share by Manufacturers in 2025
Figure 20. Top 5 and Top 10 Global Injectable HIV Treatment Players: Market Share by Revenue in Injectable HIV Treatment in 2025
Figure 21. Injectable HIV Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 22. Global Injectable HIV Treatment Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 23. North America Injectable HIV Treatment Sales Market Share by Country (2021–2032)
Figure 24. North America Injectable HIV Treatment Revenue Market Share by Country (2021–2032)
Figure 25. United States Injectable HIV Treatment Revenue Growth Rate (US$ Million), 2021–2032
Figure 26. Canada Injectable HIV Treatment Revenue Growth Rate (US$ Million), 2021–2032
Figure 27. Europe Injectable HIV Treatment Sales Market Share by Country (2021–2032)
Figure 28. Europe Injectable HIV Treatment Revenue Market Share by Country (2021–2032)
Figure 29. Germany Injectable HIV Treatment Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. France Injectable HIV Treatment Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. U.K. Injectable HIV Treatment Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Italy Injectable HIV Treatment Revenue Growth Rate (US$ Million), 2021–2032
Figure 33. Russia Injectable HIV Treatment Revenue Growth Rate (US$ Million), 2021–2032
Figure 34. Asia Pacific Injectable HIV Treatment Sales Market Share by Region (2021–2032)
Figure 35. Asia Pacific Injectable HIV Treatment Revenue Market Share by Region (2021–2032)
Figure 36. China Injectable HIV Treatment Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. Japan Injectable HIV Treatment Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. South Korea Injectable HIV Treatment Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. India Injectable HIV Treatment Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Australia Injectable HIV Treatment Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. China Taiwan Injectable HIV Treatment Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. Southeast Asia Injectable HIV Treatment Revenue Growth Rate (US$ Million), 2021–2032
Figure 43. Latin America Injectable HIV Treatment Sales Market Share by Country (2021–2032)
Figure 44. Latin America Injectable HIV Treatment Revenue Market Share by Country (2021–2032)
Figure 45. Mexico Injectable HIV Treatment Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Brazil Injectable HIV Treatment Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Argentina Injectable HIV Treatment Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Colombia Injectable HIV Treatment Revenue Growth Rate (US$ Million), 2021–2032
Figure 49. Middle East and Africa Injectable HIV Treatment Sales Market Share by Country (2021–2032)
Figure 50. Middle East and Africa Injectable HIV Treatment Revenue Market Share by Country (2021–2032)
Figure 51. Turkey Injectable HIV Treatment Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. Saudi Arabia Injectable HIV Treatment Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. UAE Injectable HIV Treatment Revenue Growth Rate (US$ Million), 2021–2032
Figure 54. Global Sales Market Share of Injectable HIV Treatment by Type (2021–2032)
Figure 55. Global Revenue Market Share of Injectable HIV Treatment by Type (2021–2032)
Figure 56. Global Injectable HIV Treatment Price (US$/Unit) by Type (2021–2032)
Figure 57. Global Sales Market Share of Injectable HIV Treatment by Application (2021–2032)
Figure 58. Global Revenue Market Share of Injectable HIV Treatment by Application (2021–2032)
Figure 59. Global Injectable HIV Treatment Price (US$/Unit) by Application (2021–2032)
Figure 60. Injectable HIV Treatment Value Chain
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
